Evidence map›Paper›PMID 36153025›Full record

ArticleBMJ open2022

Association of sarcopenia with ideal cardiovascular health metrics among US adults: a cross-sectional study of NHANES data from 2011 to 2018.

Weihua Chen, Shanshan Shi, Yizhou Jiang, Kaihong Chen, Ying Liao, Rongchong Huang, Kun Huang

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Weihua Chen *Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.ORCID 0000-0002-7670-4165
Shanshan Shi *Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Yizhou Jiang *Department of Cardiac Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Kaihong ChenDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Ying LiaoDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Rongchong HuangDepartment of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China k-huang18@mails.tsinghua.edu.cn rchuang@ccmu.edu.cn.
Kun HuangDepartment of Industrial Engineering, Tsinghua University, Beijing, China k-huang18@mails.tsinghua.edu.cn rchuang@ccmu.edu.cn.ORCID 0000-0002-7418-483X
Fujian Medical University · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe American Heart Association (AHA) proposed the concept of ideal cardiovascular health (CVH) to reduce the risk of cardiovascular mortality. We attempted to broaden the impact of CVH and further contribute to AHA 2030 goals by identifying the relationship between CVH and non-cardiovascular diseases such as sarcopenia.

designCross-sectional survey

settingNational Health and Nutrition Examination Survey conducted in the USA from 2011 to 2018.

participantsThis study included participants with reliable first 24-hour dietary recall and ≥20 years of age and excluded those who could not diagnose sarcopenia or insufficient data to calculate the CVH scores. PRIMARY AND SECONDARY OUTCOME MEASURES: The prevalence of sarcopenia as measured by dual-energy X-ray absorptiometry.

resultsThis cohort study involving 9326 adults≥20 years comprised 4733 females (50.0%). The number of intermediate or ideal and poor CVH participants was 5654 and 3672 with mean CVH score of 9.70±0.03 and 5.66±0.04, respectively. After adjusting for related confounding factors, intermediate or ideal CVH was associated with an odds reduction of sarcopenia than poor CVH (adjusted OR (aOR): 0.36, 95% CI 0.26 to 0.50, p<0.001) and the odds of sarcopenia was significantly lower for each incremental increase of 1 in CVH metrics (aOR: 0.75, 95% CI 0.71 to 0.79, p<0.001). Moreover, if the number of ideal CVH metrics was>5, the odds of sarcopenia decreased by up to 84% (aOR: 0.16, 95% CI 0.08 to 0.30).

conclusionsOur findings suggest a relationship between the CVH and the prevalence of sarcopenia in adults. The results of our study can contribute to achieving the 2030 public health goal of achieving CVH for all, which may be supported by efforts to reduce the prevalence of sarcopenia.

Indexed as

SarcopeniaAdultCohort StudiesCross-Sectional StudiesFemaleHealth StatusHumansNutrition SurveysQuality Indicators, Health CareRisk FactorsUnited StatesAdult cardiologyCardiologyPublic health

Identifiers

PMID36153025
PMCPMC9511583
OpenAlexW4297263941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.